Fact CheckerSign in

NCT07888777Not yet recruiting

Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis

The Effect of Manual Acupuncture on Intradialytic Nausea and Vomiting Scores in Patients With Chronic Kidney Disease Undergoing Routine Hemodialysis: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

This study aims to evaluate the immediate effects of acupuncture therapy at three specific acupuncture points (PC6, ST36, and KI3) on intradialysis nausea and vomiting in patients with chronic kidney disease undergoing regular hemodialysis. The outcome will be assessed using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) score one hour during the treatment and two hours after completion of hemodialysis.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
15 Oct 2026
Start date
Nov 2026
Primary completion date
Nov 2026
Lead sponsor
Universitas Indonesia
NCT number
NCT07888777

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From Nov 2026 to the primary completion date, Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects with a history of hypersensitivity reactions to previous acupuncture therapy, including stainless steel allergy, atopy, keloid formation, or other hypersensitivity reactions.

Other illness

  • Subjects with malignancies or infected wounds at the acupuncture point sites intended for intervention.
  • Subjects with primary skin diseases, such as allergic dermatitis, irritant contact dermatitis, neurodermatitis, and psoriasis.

Who the study is looking for

  • Patients with chronic kidney disease (CKD) who experience intradialytic nausea and vomiting, undergo routine hemodialysis twice weekly for at least 6 months, and are hemodynamically stable.
  • Subjects aged 18-59 years.
  • Subjects who have not received acupuncture therapy within at least one month prior to the study.
  • Subjects who are willing to participate in the study according to the scheduled protocol until completion and who have signed the informed consent form.

Age in the registry: 18 years to 59 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitas Indonesia
Coordinator of this site? Confirm its status
Jakarta PusatIndonesiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.